Patent 7390791 was granted and assigned to Gilead Sciences on June, 2008 by the United States Patent and Trademark Office.
A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a)